Dental Safety Profile of High-Dose Radioiodine Therapy

Status:
Completed

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

We aim to assess the incidence of oral and dental adverse events after high-dose radioiodine therapy for differentiated thyroid cancer.

University Hospital, Basel, Switzerland